0001209191-23-041318.txt : 20230705 0001209191-23-041318.hdr.sgml : 20230705 20230705185918 ACCESSION NUMBER: 0001209191-23-041318 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230703 FILED AS OF DATE: 20230705 DATE AS OF CHANGE: 20230705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leavitt Chase C. CENTRAL INDEX KEY: 0001777467 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50549 FILM NUMBER: 231071498 MAIL ADDRESS: STREET 1: 1010 ATLANTIC AVENUE STREET 2: SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc. CENTRAL INDEX KEY: 0001260990 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 621715807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 434-1113 MAIL ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: GTX INC /DE/ DATE OF NAME CHANGE: 20030822 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-07-03 0 0001260990 Oncternal Therapeutics, Inc. ONCT 0001777467 Leavitt Chase C. 12230 EL CAMINO REAL, SUITE 230 SAN DIEGO CA 92130 0 1 0 0 General Counsel/Secretary 0 Common Stock 2023-07-03 4 F 0 10305 0.36 D 96596 D Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. /s/Chase C. Leavitt 2023-07-05